Header Logo

Connection

Patrick Arbuthnot to Liver Neoplasms

Back to Details
This is a "connection" page, showing publications Patrick Arbuthnot has written about Liver Neoplasms.
Patrick Arbuthnot
Connection Strength
2,391
Liver Neoplasms
  1. The role of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma. Virus Res. 2016 Jan 02; 212:103-13.
    View in: PubMed
    Score: 0,477
  2. Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma. World J Gastroenterol. 2008 Mar 21; 14(11):1670-81.
    View in: PubMed
    Score: 0,286
  3. Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular Carcinoma. Front Immunol. 2022; 13:834650.
    View in: PubMed
    Score: 0,187
  4. Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach. World J Gastroenterol. 2021 Jun 21; 27(23):3182-3207.
    View in: PubMed
    Score: 0,179
  5. Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol. 2001 Apr; 82(2):77-100.
    View in: PubMed
    Score: 0,177
  6. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J Gastroenterol Hepatol. 2000 Apr; 15(4):357-68.
    View in: PubMed
    Score: 0,165
  7. In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector. Hum Gene Ther. 1996 Aug 20; 7(13):1503-14.
    View in: PubMed
    Score: 0,128
  8. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences. Hepatology. 1995 Dec; 22(6):1788-96.
    View in: PubMed
    Score: 0,122
  9. Countering hepatitis B virus infection using RNAi: how far are we from the clinic? Rev Med Virol. 2011 Nov; 21(6):383-96.
    View in: PubMed
    Score: 0,091
  10. c-fos and c-myc oncoprotein expression in human hepatocellular carcinomas. Anticancer Res. 1991 Mar-Apr; 11(2):921-4.
    View in: PubMed
    Score: 0,088
  11. Increased expression of ErbB-2 in liver is associated with hepatitis B x antigen and shorter survival in patients with liver cancer. Int J Cancer. 2009 Oct 15; 125(8):1894-901.
    View in: PubMed
    Score: 0,080
  12. Expression of c-erbA in human hepatocellular carcinomas. Anticancer Res. 1989 Jul-Aug; 9(4):885-7.
    View in: PubMed
    Score: 0,078
  13. Hepatic delivery of RNA interference activators for therapeutic application. Curr Gene Ther. 2009 Apr; 9(2):91-103.
    View in: PubMed
    Score: 0,077
  14. Hepatitis B x antigen up-regulates vascular endothelial growth factor receptor 3 in hepatocarcinogenesis. Hepatology. 2007 Jun; 45(6):1390-9.
    View in: PubMed
    Score: 0,068
  15. Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene. 2006 Feb 16; 25(7):1008-17.
    View in: PubMed
    Score: 0,062
  16. Human S15a expression is upregulated by hepatitis B virus X protein. Mol Carcinog. 2004 May; 40(1):34-46.
    View in: PubMed
    Score: 0,055
  17. A cellular gene up-regulated by hepatitis B virus-encoded X antigen promotes hepatocellular growth and survival. Hepatology. 2001 Jul; 34(1):146-57.
    View in: PubMed
    Score: 0,045
  18. Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin. Hepatology. 2006 Mar; 43(3):415-24.
    View in: PubMed
    Score: 0,016
  19. Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival. Neoplasia. 2002 Jul-Aug; 4(4):355-68.
    View in: PubMed
    Score: 0,012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.